Biogen



Ebitda تغيير تاريخ
AbbVie USD 6.92B 258M 2024-12
Acadia Pharmaceuticals USD 12.2M 22.01M 2024-12
ALKERMES USD 163.42M 40.22M 2024-12
Amgen USD 3.71B 265M 2024-12
Bayer EUR 1.67B 3.36B 2024-12
Biogen USD 754.8M 7.2M 2024-12
BioMarin Pharmaceutical USD 194.85M 18.43M 2024-12
Bristol-Myers Squibb USD 4.91B 445M 2024-12
Eli Lilly USD 6.17B 1.27B 2024-12
Gilead Sciences USD 3.21B 651M 2024-12
Incyte USD 320.2M 128.19M 2024-12
Intra Cellular Therapies USD -29088000 9.62M 2024-12
Merck USD 7.12B 1.06B 2024-12
Moderna USD -993000000 1.19B 2024-12
Neurocrine Biosciences USD 152.1M 39.2M 2024-12
Novartis USD 5.19B 319M 2024-12
Pfizer USD 4.71B 3.04B 2024-12
PTC Therapeutics USD 1.07M 47.25M 2024-12
Regeneron Pharmaceuticals USD 1.06B 572.8M 2024-12
Sanofi EUR 4.25B 2.22B 2024-09
Sanofi EUR 4.49B 2.47B 2024-09
Sarepta Therapeutics USD 182.21M 150.21M 2024-12
Teva Pharmaceutical Industries USD 261M 1.01B 2024-12
Ultragenyx Pharmaceutical USD -113199000 10.03M 2024-12
United Therapeutics USD 383.4M 43.9M 2024-12
Vertex Pharmaceuticals USD 1.16B 24.5M 2024-12



Biogen - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Mar 2025.